Clinical Trial Update: Paclitaxel Liposome for Squamous Non-Small-cell Lung Cancer Study(LIPUSU) [Phase 4]

View source ↗

Summary

Phase 4 trial update for paclitaxel liposome in squamous non-small-cell lung cancer is reported as ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Non-small Cell Lung Cancer

Drugs mentioned

• Paclitaxel liposome (liposomal paclitaxel)

Snippet

Sponsor: Nanjing Luye Sike Pharmaceutical Co., Ltd. | Conditions: Squamous Non-small-cell Lung Cancer | Phase 4 | Status: UNKNOWN